Quality of life improvement after one-year integral home-care program in IPF patients that receive nintedanib
C. Ruiz Herrero (Barcelona, Spain), L. Cobo Sanchez (Barcelona, Spain), K. Portillo (Badalona, Spain), A. Boldova Loscertales (Zaragoza, Spain), A. Robles (Mataró, Spain), J. Arribas (Zaragoza, Spain), J. Figuerola (Zaragoza, Spain), R. Blavia (Sant Joan Despí, Spain), Y. Belmonte (Sant Joan Despí, Spain), A. Moreno (Barcelona, Spain), D. Castillod (Barcelona, Spain), A. Villar (Barcelona, Spain), D. Badenes (Barcelona, Spain), D. Zayas (Barcelona, Spain), G. Suarez (Hospitalet del Llobregat, Spain), L. Garcia (Mataró, Spain), E. Balcells (Barcelona, Spain), J. Sellares (Barcelona, Spain), Y. Garcia (Barbastro, Spain), S. Barril (Lleida, Spain), J. Sans (Terrassa, Spain), M. Serra (Tortosa, Spain), D. Perich (Manresa, Spain), L. Esteban (Terrassa, Spain), J. Dorca (Hospitalet del Llobregat, Spain), P. Cerda-Cortes (Barcelona, Spain), J. Palma (Hospitalet del Llobregat, Spain), E. Ruiz (Barcelona, Spain), M. Molina Molina (Hospitalet del Llobregat, Spain)
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Ruiz Herrero (Barcelona, Spain), L. Cobo Sanchez (Barcelona, Spain), K. Portillo (Badalona, Spain), A. Boldova Loscertales (Zaragoza, Spain), A. Robles (Mataró, Spain), J. Arribas (Zaragoza, Spain), J. Figuerola (Zaragoza, Spain), R. Blavia (Sant Joan Despí, Spain), Y. Belmonte (Sant Joan Despí, Spain), A. Moreno (Barcelona, Spain), D. Castillod (Barcelona, Spain), A. Villar (Barcelona, Spain), D. Badenes (Barcelona, Spain), D. Zayas (Barcelona, Spain), G. Suarez (Hospitalet del Llobregat, Spain), L. Garcia (Mataró, Spain), E. Balcells (Barcelona, Spain), J. Sellares (Barcelona, Spain), Y. Garcia (Barbastro, Spain), S. Barril (Lleida, Spain), J. Sans (Terrassa, Spain), M. Serra (Tortosa, Spain), D. Perich (Manresa, Spain), L. Esteban (Terrassa, Spain), J. Dorca (Hospitalet del Llobregat, Spain), P. Cerda-Cortes (Barcelona, Spain), J. Palma (Hospitalet del Llobregat, Spain), E. Ruiz (Barcelona, Spain), M. Molina Molina (Hospitalet del Llobregat, Spain). Quality of life improvement after one-year integral home-care program in IPF patients that receive nintedanib. 400
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: